NCT05383248

Brief Summary

Anhedonia, i.e., reduced positive mood and decreased sensitivity to rewards, is observed in many psychiatric illnesses, particularly depression and anxiety disorders. Untreated anhedonia predicts worse clinical outcomes and poorer response to treatment, yet cognitive behavioral treatment approaches to target anhedonia are fraught with poor patient compliance in real-life settings. The proposed study aims to address this gap by 1) testing the usefulness of a non-invasive, computationally informed, cognitive training in boosting reward sensitivity and reducing anhedonia in depressed and anxious patients, and 2) delineating the neurocomputational mechanisms of change associated with such intervention. In other words, can we train the brain to obtain rewards and boost positive mood among depressed and anxious individuals? This project will help to develop a computational training protocol aimed at reducing anhedonia and improving existing interventions for psychiatric conditions characterized by reward processing deficits. Long-term goals include expanding this framework to a broader range of appetitive and social stimuli to develop precise cognitive training tools to treat anhedonia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 20, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

September 14, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2023

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

1.2 years

First QC Date

May 16, 2022

Last Update Submit

November 28, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Reward Maximization

    Individually fitted computational parameter of reward maximization strategy during the reward learning task

    Change between Pre-Training and Post-Training Assessments (about 20 min)

  • Positive Affect

    State positive affect measured with the Positive and Negative Affect Schedule (PANAS)

    Change between Pre-Training and Post-Training Assessments (about 20 min)

  • Neural Tracking of Reward Expectation

    Neural activity, i.e., blood oxygen level dependent (BOLD) response, in the striatum and medial prefrontal cortex correlating with participants' trial-level model-based reward expectations and associated prediction errors during the Reward Learning Task

    Change between Pre-Training and Post-Training Assessments (about 20 min)

Study Arms (2)

High Reward - High Variance

EXPERIMENTAL
Behavioral: High Reward - High Variance

High Reward - Low Variance

ACTIVE COMPARATOR
Behavioral: High Reward - Low Variance

Interventions

Computerized reward learning task designed to increase reward responsiveness

High Reward - High Variance

Computerized reward learning task designed to have minimal effect on reward responsiveness

High Reward - Low Variance

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 (all races, both males and females will be included)
  • Current diagnosis of Major Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD)
  • A score \< 7 on the Snaith-Hamilton Pleasure Scale (SHAPS) or \< 25 on the Positive Affect subscale from the Positive And Negative Affect Scale (PANAS)
  • Sufficient proficiency in English language to understand and complete informed consent, interviews, questionnaires, and all other study procedures.
  • Having normal or corrected vision
  • Having normal or corrected hearing

You may not qualify if:

  • Endorsement of past or current psychotic or bipolar disorder.
  • Endorsement of recent severe alcohol or substance use disorder (past 3 months).
  • Inability to discontinue for 48 hours prior to scan any medications incompatible with measuring reliable/interpretable neural activity (e.g., e.g., benzodiazepines/beta-blockers, atypical anti-depressants, anxiolytics and sedative hypnotics, antipsychotics, and opioid analgesics)
  • Being unsafe to undergo functional magnetic resonance imaging (fMRI), i.e., being pregnant, presence of non-removable metal in body, medical conditions that are incompatible with safe MRI (e.g., claustrophobia, inability to lie still on one's back for approximately 60 minutes; prior neurosurgery)
  • Clinical conditions assessed by the interviewer that necessitate more imminent clinical care (e.g., active suicidal ideation): These criteria are in place so participants with these other, more several symptoms can be referred for appropriate mental health services.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSD Center for Functional Magnetic Resonance Imaging

La Jolla, California, 92093, United States

Location

MeSH Terms

Conditions

AnhedoniaDepression

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Clinical Professor

Study Record Dates

First Submitted

May 16, 2022

First Posted

May 20, 2022

Study Start

September 14, 2022

Primary Completion

November 16, 2023

Study Completion

November 16, 2023

Last Updated

November 29, 2023

Record last verified: 2023-11

Locations